Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ershiliu Wei Tongjing Jiaonang (二十六味通经胶囊) is a traditional Tibetan medicine herbal formulation developed and manufactured by Qinghai Jiumei Tibetan Medicine Pharmaceutical Co., Ltd. The formulation consists of 26 herbal and animal-derived ingredients, including Dalbergia odorifera (降香), safflower (红花), Inula helenium (藏木香), Rubia cordifolia (藏茜草), Terminalia chebula (诃子), Arnebia (紫草茸), cinnabar (朱砂), antelope horn (羚羊角), and sea buckthorn paste (沙棘膏). According to Tibetan medicine principles, it functions to harmonize 'dragon blood' and regulate meridians, while in traditional Chinese medicine terms, it promotes blood circulation, disperses blood stasis, regulates menstruation, and relieves pain. It is approved in China (approval number: 国药准字Z20026511) for the treatment of menstrual disorders, amenorrhea (闭经), irregular menstruation, and various pains (chest, back, lower abdomen, and waist) resulting from blood stasis blocking the meridians.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ershiliu Wei Tongjing Jiaonang.